Search Results for: MRK
GTx, Inc. (NASDAQ: GTXI) is seeing shares trade sharply higher on a collaboration pact with Merck (NYSE: MRK). The biotech and drug giant pact is for research and development and a strategic...
Published:
Vioxx lawsuit could drag on for years, even a decade. But, Merck is looking ahead. It confirmed 2006 guidance and said that 2007 would be in the range Wall St. hopes for. The company is sending a...
Published:
Short interest in Pfizer rose 6.8 million shares to 51.1 million in December. Market fears that generics will eat away at revenues at Big Pharma is not helping. But, Pfizer is unique now. Its new...
Published:
Merck & Co., Inc. (NYSE: MRK) barely has its Schering-Plough deal behind it. And today came the announcement of its dividend rate, but more importantly came word of a large share repurchase...
Published:
Last Updated:
By Chad Brand of Peridot CapitalistWhen I wrote about the Merck (MRK) deal to acquire Sirna Therapeutics (RNAI) on 10/31 and predicted more biotech deals were coming, I didn’t realize it would...
Published:
Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week. Merck plans to emerge next year and into the next decade leaner and more...
Published:
Like most of the Big Pharma companies, Merck needs a winner. Wall St. is scared witless that generic drug firms like Teva will scoop up all of the customers as drugs come off patent.With Wal-Mart and...
Published:
So much fore feeling better in a bad economy.Merck (MRK) offered lackluster guidance for next year and the stock is off before the open. According to Reuters, "Merck said it expected earnings,...
Published:
Last Updated:
It is easy to get pumped up about overseas rate cuts, but there is cautionary data from at least three DJIA components. Wal-Mart is the economic trade-down so that win in retail sales is a...
Published:
Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company’s news about it Transcranial Ultrasound in Clinical SONolysis clinical trial in patients with acute ischemic stroke...
Published:
Last Updated:
So far we have three DJIA components with earnings out. DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies (NYSE: UTX) have all posted earnings. So far there are no train wrecks...
Published:
Last Updated:
Big Pharma continues to throw ballast out of the balloon in the hopes of staying aloft. The latest victim of declining fortunes in the industry is Merck (MRK), which seems to have had every drug...
Published:
Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that findings from its head-to-head, double-blind trial comparing the...
Published:
Last Updated: